Ingevec Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Ingevec şirketinin toplam hissedar öz sermayesi CLP79.6B ve toplam borcu CLP81.3B olup, bu da borç-öz sermaye oranını 102.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CLP247.8B ve CLP168.1B dir. Ingevec 'in FAVÖK'ü CLP9.6B faiz karşılama oranı 2.5 dur. Şirketin CLP15.6B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

102.2%

Borç/özkaynak oranı

CL$81.34b

Borç

Faiz karşılama oranı	2.5x
Nakit	CL$15.62b
Eşitlik	CL$79.61b
Toplam yükümlülükler	CL$168.15b
Toplam varlıklar	CL$247.76b

Son finansal sağlık güncellemeleri

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Extensively

Jun 14

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Reasonably Well

Jan 11

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Apr 12

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Jan 11

Recent updates

Even With A 26% Surge, Cautious Investors Are Not Rewarding Ingevec S.A.'s (SNSE:INGEVEC) Performance Completely

Jan 26

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Extensively

Jun 14

A Look At The Intrinsic Value Of Ingevec S.A. (SNSE:INGEVEC)

Feb 16

Slowing Rates Of Return At Ingevec (SNSE:INGEVEC) Leave Little Room For Excitement

Sep 02

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Reasonably Well

Jan 11

Key Things To Consider Before Buying Ingevec S.A. (SNSE:INGEVEC) For Its Dividend

Jan 26

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Jan 11

Did You Participate In Any Of Ingevec's (SNSE:INGEVEC) Incredible 423% Return?

Dec 23

We Wouldn't Rely On Ingevec's (SNSE:INGEVEC) Statutory Earnings As A Guide

Dec 01

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: INGEVEC 'nin kısa vadeli varlıkları ( CLP126.3B ) kısa vadeli yükümlülüklerini ( CLP125.3B ) aşıyor.

Uzun Vadeli Yükümlülükler: INGEVEC şirketinin kısa vadeli varlıkları ( CLP126.3B ) uzun vadeli yükümlülüklerini ( CLP42.8B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: INGEVEC 'nin net borç/öz sermaye oranı ( 82.5% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: INGEVEC şirketinin borç/öz sermaye oranı son 5 yılda 69.4% seviyesinden 102.2% seviyesine yükseldi.

Borç Kapsamı: INGEVEC 'nin borcu işletme nakit akışı ( 19.7% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: INGEVEC 'in borcuna ilişkin faiz ödemeleri EBIT ( 2.5 x kapsam) tarafından iyi karşılanmıyor.

Ingevec Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Extensively

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Reasonably Well

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Recent updates

Upcoming dividend of CL$2.90 per share

First quarter 2024 earnings released: EPS: CL$3.00 (vs CL$2.70 in 1Q 2023)

New major risk - Financial position

Full year 2023 earnings released: EPS: CL$9.70 (vs CL$9.30 in FY 2022)

Even With A 26% Surge, Cautious Investors Are Not Rewarding Ingevec S.A.'s (SNSE:INGEVEC) Performance Completely

Investor sentiment improves as stock rises 15%

Third quarter 2023 earnings released: EPS: CL$2.07 (vs CL$2.24 in 3Q 2022)

New major risk - Financial position

Second quarter 2023 earnings released: EPS: CL$2.68 (vs CL$2.49 in 2Q 2022)

Investor sentiment improves as stock rises 17%

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Extensively

Full year 2022 earnings released: EPS: CL$9.30 (vs CL$8.60 in FY 2021)

A Look At The Intrinsic Value Of Ingevec S.A. (SNSE:INGEVEC)

Now 21% undervalued after recent price drop

Less than half of directors are independent

Investor sentiment improved over the past week

Slowing Rates Of Return At Ingevec (SNSE:INGEVEC) Leave Little Room For Excitement

Second quarter 2022 earnings released: EPS: CL$2.49 (vs CL$2.08 in 2Q 2021)

First quarter 2022 earnings released: EPS: CL$2.70 (vs CL$2.20 in 1Q 2021)

Upcoming dividend of CL$4.30 per share

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Reasonably Well

The Returns At Ingevec (SNSE:INGEVEC) Aren't Growing

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CL$2.21 (vs CL$0.97 in 3Q 2020)

Second quarter 2021 earnings released: EPS CL$2.08 (vs CL$0.06 in 2Q 2020)

Here's What's Concerning About Ingevec's (SNSE:INGEVEC) Returns On Capital

First quarter 2021 earnings released: EPS CL$2.20 (vs CL$1.72 in 1Q 2020)

Upcoming dividend of CL$1.56 per share

Calculating The Fair Value Of Ingevec S.A. (SNSE:INGEVEC)

Upcoming dividend of CL$1.56 per share

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Full year 2020 earnings released: EPS CL$5.20 (vs CL$7.80 in FY 2019)

New 90-day high: CL$90.00

Here’s What’s Happening With Returns At Ingevec (SNSE:INGEVEC)

Is Ingevec S.A.'s (SNSE:INGEVEC) ROE Of 9.7% Impressive?

Key Things To Consider Before Buying Ingevec S.A. (SNSE:INGEVEC) For Its Dividend

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Did You Participate In Any Of Ingevec's (SNSE:INGEVEC) Incredible 423% Return?

New 90-day low: CL$79.78

We Wouldn't Rely On Ingevec's (SNSE:INGEVEC) Statutory Earnings As A Guide

Third quarter 2020 earnings released: EPS CL$0.97

New 90-day low: CL$82.25

New 90-day low: CL$85.20

First half earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin